Sparton (SPA) Misses Q3 EPS by 8c, Miss on Revenues
Tweet
Share
E-mailGet Alerts SPA Hot Sheet
Price: $18.51 --0%
Financial Fact:
Internal research and development expenses: 351K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Internal research and development expenses: 351K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Sparton (NYSE: SPA) reported Q3 EPS of $0.22, $0.08 worse than the analyst estimate of $0.30. Revenue for the quarter came in at $95.4 million versus the consensus estimate of $100.75 million.
For earnings history and earnings-related data on Sparton (SPA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Range Impact, Inc. (RNGE) Reports Q2 Loss of $0.02
- McGraw Hill (MH) Tops Q2 EPS by 11c, Beats on Revenue; Offers FY26 Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
